News Focus
News Focus
icon url

alertmeipp

06/23/12 10:05 AM

#9169 RE: pollyvonwog #9168

Yes, that's my understanding.

The difference is whether MNTA waits for all these as a underdog or not.
icon url

oldberkeley

06/23/12 10:17 AM

#9170 RE: pollyvonwog #9168

So even if MNTA had won, it would of [sic] been a tentative approval with all the appeals right?

It would have been a legal decision subject to appeal, as most are and as this one is.

Be that as it may, the market despises uncertainty and MNTA is screwed for awhile. FWIW, looking to average down in the $12's on Monday.
icon url

mouton29

06/23/12 1:47 PM

#9177 RE: pollyvonwog #9168

<<So even if MNTA had won, it would of been a tentative approval with all the appeals right?>>

You seem to be confusing two different hurdles, the first is FDA approval, the second is TEVA patents. The litigation with TEVA sought to declare TEVA's patents invalid, but MNTA still needs FDA approval to launch their generic. And if FDA approval is obtained, MNTA can launch once the TEVA patents have expired in 2015, even putting aside the outcome of any appeal.
icon url

DewDiligence

06/23/12 2:42 PM

#9186 RE: pollyvonwog #9168

So even if MNTA had won, it would of been a tentative approval with all the appeals right?

No—please see #msg-76904920 and #msg-76905055.